PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a) - Concepedia

Concepedia

Publication | Closed Access

PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)

67

Citations

28

References

2020

Year

Gerald F. Watts, Dick C. Chan, Jing Pang, Louis Ma, Qidi Ying, Shashi Aggarwal, Santica M. Marcovina, P. Hugh R. Barrett

InflammationMetabolic SyndromeBiochemistryCardiovascular DiseaseMedicinePcsk9 InhibitionImmunologyHyperlipidemiaLipoprotein MetabolismStatin-treated PatientsPharmacologyElevated LipoproteinAtherosclerosisDyslipidemiaOxidative Stress

References

	Year	Citations

Page 1

Page 1